Trial completion date • Trial initiation date • Trial primary completion date • CAR T-Cell Therapy
|
BCL2 (B-cell CLL/lymphoma 2) • CD19 (CD19 Molecule) • BCL6 (B-cell CLL/lymphoma 6)
|
CD19 expression • BCL6 rearrangement • BCL2 rearrangement
|
cyclophosphamide • fludarabine IV • CD19-CD34t metabolically programmed CAR transduced T-cells